Hypophosphorous Acid

Hypophosphorous Acid

SCHEMBL4938253

CCCCCN=Nc1nc(C)c(O)c(C=O)c1COP(=O)(O)O.O=[PH2]O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 3/20 0.56
YWHAG P61981 1/20 0.56
YWHAZ P63104 1/20 0.56
P2RY1 P47900 4/20 0.54
P2RY13 Q9BPV8 4/20 0.52
PLA2G2A P14555 1/20 0.52
MAPT P10636 5/20 0.51
TDP1 Q9NUW8 5/20 0.51
KDM4E B2RXH2 3/20 0.51
P2RX2 Q9UBL9 3/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
P2RX3 P56373 2/20 0.51
HPGD P15428 2/20 0.51
HSD17B10 Q99714 2/20 0.51
ALDH1A1 P00352 2/20 0.51
CASP1 P29466 1/20 0.51
CYP2C19 P33261 1/20 0.51
RAB9A P51151 1/20 0.51
CASP7 P55210 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4934793 0.96 P2RX7 (0.60) P2RX7YWHAGYWHAZP2RY1P2RY13
SCHEMBL13962115 0.73 P2RY1 (0.71) P2RX7YWHAGYWHAZP2RY1P2RY13
SCHEMBL25236715 0.73 P2RX7 (0.68) P2RX7YWHAGYWHAZP2RY1P2RY13
SCHEMBL14702229 0.72 P2RX7 (1.00) P2RX7YWHAGYWHAZP2RY1P2RY13
SCHEMBL32686684 0.72 P2RX7 (1.00) P2RX7YWHAGYWHAZP2RY1P2RY13
SCHEMBL25271476 0.72 P2RX7 (1.00) P2RX7YWHAGYWHAZP2RY1P2RY13
SCHEMBL7091297 0.71 P2RX7 (0.83) P2RX7YWHAGYWHAZP2RY1P2RY13
SCHEMBL7090990 0.71 P2RX7 (0.74) P2RX7YWHAGYWHAZP2RY1P2RY13
SCHEMBL7093516 0.71 P2RX7 (0.83) P2RX7YWHAGYWHAZP2RY1P2RY13
SCHEMBL7094651 0.71 P2RX7 (0.74) P2RX7YWHAGYWHAZP2RY1P2RY13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080076738-A1 Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds GILEAD SCIENCES, INC. 2008-03-27 US disclosed
EP-1742642-A2 PHOSPHONATE ANALOGS OF HIV INTEGRASE INHIBITOR COMPOUNDS GILEAD SCIENCES, INC. (US) 2007-01-17 EP disclosed
US-20060116356-A1 Phosphonate analogs of HIV integrase inhibitor compounds GILEAD SCIENCES, INC. 2006-06-01 US disclosed
WO-2005117904-A2 PHOSPHONATE ANALOGS OF HIV INTEGRASE INHIBITOR COMPOUNDS GILEAD SCIENCES, INC. (US) 2005-12-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060116356-A1 Phosphonate analogs of HIV integrase inhibitor compounds TYMP, PNP, PIKFYVE P2RX7 4498/4885YWHAG 1992/4885YWHAZ 3646/4885
US-20080076738-A1 Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds TYMP, PNP, PIKFYVE P2RX7 4498/4885YWHAG 1992/4885YWHAZ 3646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.